Table 1 Baseline characteristics of study participants
Age (years) | 57 (16) |
|---|---|
Sex | |
Female | 85 (33.2%) |
Male | 170 (66.8%) |
Vaccinated | 51 (20.0%) |
Race | |
White | 44 (17.2%) |
American Indian/Alaska Native | 2 (0.8%) |
Asian | 45 (17.6%) |
Black/African-American | 22 (8.6%) |
Native Hawaiian/Other Pacific Islander | 8 (3.1%) |
Other/Multiple, refused, or unknown | 1 34 (52.3%) |
Ethnicity | |
Hispanic/Latino | 136 (53.5%) |
Not Hispanic/Latino | 115 (44.9%) |
Patient Refused or unknown | 4 (1.6%) |
BMI (kg/m2) | 29.9 (25.4–35.4) |
Baseline O2 saturation (n = 254) | 95 (90–97) |
Baseline WHO ordinal scale | |
Hospitalized, No O2 | 46 (18.0%) |
NC < 6L | 93 (36.5%) |
> 6L, HFNO, or NIV | 57 (22.4%) |
MV | 10 (3.9%) |
MV + organ support | 49 (19.2%) |
Symptom duration (days) (n = 236) | 8 (5–10) |
Cigarette smoker (n = 254) | |
Never | 161 (63.4%) |
Former | 57 (22.4%) |
Current | 21 (8.3%) |
Unknown | 15 (5.9%) |
Vaping (n = 254) | |
Never | 172 (67.7%) |
Current | 2 (0.8%) |
Unknown | 80 (31.5%) |
Hypertension (n = 255) | 126 (49.6%) |
CKD (n = 255) | 38 (15.0%) |
Diabetes (n = 244) | 93 (38.1%) |
Immunosuppression | 39 (15.3%) |